Dr Sarah Eminli-Meissner

Dr Sarah Eminli-Meissner
Head of Business – Stem Cells and Global Director, Commercial R&D

Recent Posts

Factors to consider when planning a iPSC reprogramming project

[fa icon="calendar'] May 18, 2018 8:03:40 AM / by Dr Sarah Eminli-Meissner

[fa icon="comment"] 0 Comments

When you are considering beginning a project involving iPSC reprogramming, there are several factors to consider when choosing a reprogramming technology and a service provider.

Continue reading [fa icon="long-arrow-right"]